Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. Walsh, D. Divilly, R. Rutherford, J. J. Gilmartin (Galway, Ireland). Evaluation of thyroid function in patients with suspected obstructive sleep apnoea syndrome. Eur Respir J 2010; 36: Suppl. 54, 4427

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of thyroid disease in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism? Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism Source: Sleep and Breathing Conference 2021 Year: 2021 Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006 Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Evaluation of renal function in a cohort of patients affected by obstructive sleep apnea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006 Respiratory muscle function in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 419s Year: 2001 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Prevalance and characteristics of overlap syndrome in patients with obstructive sleep apnea Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002 Myocardial alterations in asymptomatic patients with obstructive sleep apnea syndrome Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Enuresis in obstructive sleep apnea syndrome patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002 Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Predictors of obstructive sleep apnea syndrome and metabolic syndrome Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012